Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy-Reference-Cited by-同舟云学术

Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy

Published:2019-08-14 Issue:5 Volume:300 Page:1261-1270
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Phillips Andrew^ORCID,Kehoe Sean,Singh Kavita,Elattar Ahmed,Nevin James,Balega Janos,Pounds Rachel,Elmodir Ahmed,Pascoe Jennifer,Fernando Indrajit,Sundar Sudha

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00404-019-05269-8.pdf

Reference39 articles.

1. Horowitz NS, Miller A, Rungruang B, Richard SD, Rodriguez N, Bookman MA et al (2015) Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin Oncol 33(8):937–943

2. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom [AGO-OVAR] and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire [GINECO]. Cancer 115(6):1234–1244

3. Markman M, Rothman R, Hakes T, Reichman B, Hoskins W, Rubin S et al (1991) Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin. J Clin Oncol 9(3):389–393

4. Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C, et al. (2013) Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 24(Suppl 6):vi24–32.

5. Wright AA, Bohlke K, Armstrong DK, Bookman MA, Cliby WA, Coleman RL et al (2016) Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Gynecol Oncol 143(1):3–15

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Barriers to cancer treatment for people experiencing socioeconomic disadvantage in high-income countries: a scoping review;BMC Health Services Research;2024-05-28

2. Where are the inequalities in ovarian cancer care in a country with universal healthcare? A systematic review and narrative synthesis;Journal of Cancer Policy;2024-03

3. Syndemic Geographic Patterns of Cancer Types in a Health Deprived Area of England: a new Paradigm for Public Health Cancer Interventions?;2024-02-27

4. Barriers to cancer treatment and care for people experiencing structural vulnerability: a secondary analysis of ethnographic data;International Journal for Equity in Health;2023-03-30

5. Factor Analysis of Health Care Access With Ovarian Cancer Surgery and Gynecologic Oncologist Consultation;JAMA Network Open;2023-02-01